We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+10.12%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$6.71B
AUM Growth
+$2.5B
(+59%)
Cap. Flow
+$2.05B
Cap. Flow
% of AUM
30.61%
Top 10 Holdings %
Top 10 Hldgs %
14.85%
Holding
2,565
New
44
Increased
937
Reduced
347
Closed
1,235
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$92.8M |
| 2 |
Microsoft
MSFT
|
+$58.3M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$56.5M |
| 4 |
ExxonMobil
XOM
|
+$46.3M |
| 5 |
Chevron
CVX
|
+$29.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DELL
DELL INC
DELL
|
+$4.89M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$3.48M |
| 3 |
NYX
NYSE EURONEXT INC
NYX
|
+$3.27M |
| 4 |
CoStar Group
CSGP
|
+$2.8M |
| 5 |
VPHM
VIROPHARMA INC
VPHM
|
+$2.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.32% |
| 2 | Technology | 15.24% |
| 3 | Healthcare | 12.35% |
| 4 | Industrials | 9.18% |
| 5 | Consumer Discretionary | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Flex
FLEX
$43.4B
| $209K | ﹤0.01% |
35,724
-10,863
| -23% | -$66K |
|
1252
Portland General Electric
POR
$6.02B
| $209K | ﹤0.01% |
6,905
-42,069
| -86% | -$1.24M |
|
1253
Jack in the Box
JACK
$278M
| $207K | ﹤0.01% |
4,135
-25,126
| -86% | -$1.11M |
|
1254
CACI
CACI
$10.8B
| $206K | ﹤0.01% |
2,819
-12,731
| -82% | -$903K |
|
1255
ServiceNow
NOW
$102B
| $206K | ﹤0.01% |
+18,415
| New | +$195K |
|
1256
Sinclair Inc
SBGI
$974M
| $205K | ﹤0.01% |
5,736
-37,818
| -87% | -$1.27M |
|
|
TRW
1257
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
| $203K | ﹤0.01% |
2,723
-518
| -16% | -$39K |
|
|
CEMP
1258
DELISTED
Cempra, Inc.
CEMP
| $199K | ﹤0.01% |
16,029
+3,549
| +28% | +$42.9K |
|
1259
PTC Therapeutics
PTCT
$6.37B
| $198K | ﹤0.01% |
+11,644
| New | +$205K |
|
1260
BioCryst Pharmaceuticals
BCRX
$2.37B
| $197K | ﹤0.01% |
+25,886
| New | +$164K |
|
|
ECYT
1261
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $194K | ﹤0.01% |
18,127
-13,780
| -43% | -$152K |
|
|
IMMU
1262
DELISTED
Immunomedics Inc
IMMU
| $193K | ﹤0.01% |
41,951
-33,500
| -44% | -$149K |
|
|
CMRX
1263
DELISTED
Chimerix, Inc.
CMRX
| $185K | ﹤0.01% |
+12,214
| New | +$195K |
|
|
SCMP
1264
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $185K | ﹤0.01% |
19,637
-3,932
| -17% | -$28.1K |
|
|
LEAP
1265
DELISTED
LEAP WIRELESS INTERNATIONAL INC NEW
LEAP
| $181K | ﹤0.01% |
10,406
-29,286
| -74% | -$482K |
|
1266
8x8 Inc
EGHT
$247M
| $176K | ﹤0.01% |
17,276
-36,165
| -68% | -$369K |
|
1267
Omeros
OMER
$709M
| $175K | ﹤0.01% |
15,527
-13,788
| -47% | -$133K |
|
1268
Skywest
SKYW
$4.11B
| $172K | ﹤0.01% |
11,608
-31,680
| -73% | -$482K |
|
1269
Pacific Biosciences
PACB
$422M
| $171K | ﹤0.01% |
32,698
-20,595
| -39% | -$94.6K |
|
1270
Scorpio Tankers
STNG
$3.96B
| $169K | ﹤0.01% |
1,436
-10,292
| -88% | -$1.15M |
|
|
CBB
1271
DELISTED
Cincinnati Bell Inc.
CBB
| $167K | ﹤0.01% |
9,383
-22,831
| -71% | -$357K |
|
|
PGNX
1272
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $166K | ﹤0.01% |
31,160
-27,855
| -47% | -$123K |
|
|
ACHN
1273
DELISTED
Achillion Pharmaceuticals
ACHN
| $165K | ﹤0.01% |
49,624
-45,312
| -48% | -$131K |
|
|
AMRI
1274
DELISTED
Albany Molecular Research Inc
AMRI
| $158K | ﹤0.01% |
15,658
-10,209
| -39% | -$123K |
|
1275
Cousins Properties
CUZ
$5.29B
| $153K | ﹤0.01% |
5,250
-33,926
| -87% | -$1.02M |
|
Similar funds
ProShare Advisors's Q4 2013 Portfolio in Review
As of Q4 2013, ProShare Advisors held 2,565 positions worth $6.71B, up 59% from $4.21B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
ProShare Advisors deployed $2.05B of net new capital in Q4 2013, opening 44 new positions and adding to 937 existing holdings. Its largest new stake was VEON: 13,524 shares worth $4.38M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was CoStar Group, an estimated $2.8M trimmed.
- ProShare Advisors's largest Q4 2013 buy was VEON: 13,524 shares worth $4.38M.
- ProShare Advisors added most to Apple in Q4 2013, an estimated $92.8M increase.
- ProShare Advisors's biggest Q4 2013 reduction was CoStar Group, cutting an estimated $2.8M.
- ProShare Advisors fully exited DELL INC in Q4 2013, selling an estimated $4.89M.
- ProShare Advisors's ten largest holdings make up 15% of its $6.71B portfolio in Q4 2013.
- ProShare Advisors opened 44 new positions and closed 1,235 in Q4 2013.
- ProShare Advisors's portfolio value rose 59% quarter-over-quarter to $6.71B.
Based on ProShare Advisors's 13F filing for Q4 2013, filed 4 Feb 2014.